00

Jiuzhitang Co LtdSHE 000989 Stock Report

Last reporting period 30 Sep, 2023

Updated 04 Nov, 2024

Last price

Market cap $B

0.805

Micro

Exchange

XSHE - Shenzhen Stock Exchange

000989.SZ Stock Analysis

00

Avoid

Based on Eyestock quantitative analysis, 000989.SZ`s fundamental data and valuation indicate an investment grade of Avoid at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

43/100

Low score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

29.7 %

Undervalued

Market cap $B

0.805

Dividend yield

10.27 %

Shares outstanding

842.53 B

Jiuzhitang Co., Ltd. is engaged in the developing, manufacturing, wholesaling and retailing of Chinese medicines, Chinese medicinal materials, Western medicines, biological pharmaceuticals, biological preparations, chemical raw materials, chemical reagents and health food. The company is headquartered in Beijing, Beijing and currently employs 4,777 full-time employees. The company went IPO on 2000-06-28. is a China-based company principally engaged in the research, development, production and distribution of Chinese patent drugs. The firm provides products through three categories, which include over the counter (OTC) drugs, prescription drugs and comprehensive health series. The Company’s main products include Liuwei Dihuang pills, Xiaoyao pills, Shuxuetong injection, compound Jiangzhi tablets and E-Jiao series health products, among others. The firm distributes its products in domestic market.

View Section: Eyestock Rating